Prostate Health Index (PHI)

Prostate screening consists of determining the PSA level (prostate-specific antigen) through a blood test and a physical examination. Elevated PSA levels indicate prostate disease, such as prostate cancer, prostatitis, or benign enlargement. The blood test is complemented by a physical examination, which is painless.

Prostate Pro Panel

At Dr. Rose Private Hospital, the Prostate Pro Panel—also known as the Prostate Health Index (PHI) test—is available for determining PSA levels from a blood sample.
The PHI is a combined test that calculates a composite risk score using the ratio of three different PSA isoforms, providing a more accurate indication of the likelihood of clinically significant prostate cancer.
Based on the test results, it can be determined with greater certainty what further examinations are needed and when the PHI measurement should be repeated.

Advantages of the PHI test

  • While PSA is primarily organ-specific, p2PSA (a component of PHI) is a tumor-specific marker.
  • The PHI test is three times more effective at detecting the likelihood of prostate cancer than PSA alone.
  • It supports early diagnosis and helps assess the aggressiveness of the cancer.
  • Knowing the result can reduce the number of unnecessary biopsies.
  • The test is also suitable for monitoring an existing condition. 

It is important to note that malignant prostate disease (prostate cancer) is completely asymptomatic in its early stages. Therefore, screening is recommended for all men over the age of 40.